|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.910 NZD | 0.00% |
|
+6.83% | +15.68% |
| 07-07 | AFT Pharmaceuticals On Track to Achieve Fiscal 2027 Revenue Target; Iron Injectable Product Clears Regulatory Hurdles | MT |
| 06-24 | NZX Biggest Gainers | MT |
| Market Cap | 410M 236M 206M 190M 176M 334M 22.52B 340M 2.28B 893M 11.06B 886M 867M 38.31B | P/E 2027 * |
20.8x | P/E 2028 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 440M 253M 221M 204M 189M 359M 24.16B 365M 2.45B 958M 11.86B 950M 930M 41.09B | EV / Sales 2027 * |
1.45x | EV / Sales 2028 * | 1.26x |
| Free-Float |
22.37% | Yield 2027 * |
0.84% | Yield 2028 * | 1.06% |
Last Transcript: AFT Pharmaceuticals Limited
| 20/01/24 | Rentevrees zet Bel20 onder druk | |
| 19/01/24 | KBC uitblinker op groene beurs | |
| 19/01/24 | Brusselse beurs opent flink hoger | |
| 19/01/24 | Brussel start handelsdag vermoedelijk in het groen | |
| 18/01/24 | Hyloris gaat samenwerken met AFT Pharmaceuticals |
| 1 week | +6.83% | ||
| Current month | +6.83% | ||
| 1 month | -0.51% | ||
| 3 months | +7.71% | ||
| 6 months | +10.14% | ||
| Current year | +15.68% |
| 1 week | 3.67 |  | 4 |
| 1 month | 3.65 | | 4 |
| Current year | 3.35 | | 4 |
| 1 year | 2.54 | | 4 |
| 3 years | 2.37 | | 4 |
| 5 years | 2.37 | | 5 |
| 10 years | 1.7 | | 5.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marree Atkinson
HRO | Human Resources Officer | - | 03/09/2012 |
Hartley Atkinson
CEO | Chief Executive Officer | - | 03/09/1997 |
Stuart Houliston
DFI | Director of Finance/CFO | - | 14/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
David Flacks
CHM | Chairman | - | 21/06/2015 |
Hartley Atkinson
BRD | Director/Board Member | - | 03/09/1997 |
Marree Atkinson
BRD | Director/Board Member | - | 03/09/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/07/25 | Buy | Founder | 200,000 | 0.1907% | ||
| 25/06/25 | Free | Founder | 17,755 | 0.0169% | ||
| 01/12/24 | Buy | Founder | 45 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +6.83% | +42.70% | +9.22% | 233M | |
| +0.09% | +2.12% | +56.49% | +169.19% | 1,084B | |
| -1.63% | +2.02% | +66.31% | +62.70% | 634B | |
| -1.12% | -0.46% | +31.69% | +84.44% | 447B | |
| +0.18% | +2.04% | +30.19% | +26.51% | 330B | |
| -6.22% | -3.61% | +29.15% | +32.09% | 295B | |
| -1.27% | -0.56% | +27.21% | +46.39% | 285B | |
| -0.93% | -1.19% | -28.85% | -40.38% | 218B | |
| -1.19% | +0.63% | +22.43% | +66.30% | 199B | |
| -0.72% | +7.04% | +21.41% | +81.19% | 169B | |
| Average | -1.29% | +2.84% | +29.87% | +53.76% | 366.01B | |
| Weighted average by Cap. | -1.12% | +2.48% | +39.76% | +84.80% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304M 175M 153M 141M 130M 248M 16.69B 252M 1.69B 662M 8.19B 656M 642M 28.39B | 345M 199M 174M 160M 148M 281M 18.96B 286M 1.92B 752M 9.31B 746M 730M 32.26B |
| Net income | 19.71M 11.34M 9.92M 9.15M 8.46M 16.07M 1.08B 16.33M 110M 42.94M 532M 42.57M 41.65M 1.84B | 24.84M 14.29M 12.5M 11.53M 10.67M 20.24M 1.36B 20.58M 138M 54.12M 670M 53.65M 52.49M 2.32B |
| Net Debt | 29.84M 17.17M 15.02M 13.85M 12.81M 24.32M 1.64B 24.73M 166M 65.02M 805M 64.45M 63.06M 2.79B | 24.59M 14.15M 12.38M 11.41M 10.56M 20.04M 1.35B 20.38M 137M 53.58M 663M 53.11M 51.96M 2.3B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | NZ$3.910 | 0.00% | 65,764 |
| 08/07/26 | NZ$3.910 | +0.51% | 17,313 |
| 07/07/26 | NZ$3.890 | +4.85% | 26,498 |
| 06/07/26 | NZ$3.710 | +0.27% | 10,511 |
| 03/07/26 | NZ$3.700 | +0.82% | 3,160 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AFT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
